Stay updated on MK-4830 Monotherapy & Combination With Pembrolizumab Clinical Trial

Sign up to get notified when there's something new on the MK-4830 Monotherapy & Combination With Pembrolizumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the MK-4830 Monotherapy & Combination With Pembrolizumab Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T21:45:47.000Z thumbnail image
  4. Check
    3 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the study details related to the evaluation of the safety, tolerability, and preliminary efficacy of MK-4830 monotherapy administration and in combination with pembrolizumab for participants with advanced solid tumors.
    Difference
    0.1%
    Check dated 2024-06-06T14:28:50.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for participants, specifying health conditions and prior treatments required for inclusion in the study. Previously, this section had no information provided.
    Difference
    53%
    Check dated 2024-05-22T20:29:59.000Z thumbnail image
  8. Check
    26 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 03 25 10 25 10 25 03 22 03 25 03 to 05 17 09 28 09 28 05 16 05 17 05. This change likely represents an update or modification in the data related to the study of MK-4830 as Monotherapy and in Combination With Pembrolizumab for Participants With Advanced Solid Tumors.
    Difference
    0.6%
    Check dated 2024-05-21T12:35:13.000Z thumbnail image
  9. Check
    46 days ago
    Change Detected
    Difference
    0.5%
    Check dated 2024-04-30T22:01:54.000Z thumbnail image

Stay in the know with updates to MK-4830 Monotherapy & Combination With Pembrolizumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the MK-4830 Monotherapy & Combination With Pembrolizumab Clinical Trial page.